Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2010-07-09 (15 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: VEYNES (05400), Hautes-Alpes
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE CENTRALE VEYNES : revenue, balance sheet and financial ratios
PHARMACIE CENTRALE VEYNES is a French company
founded 15 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in VEYNES (05400),
this company of category PME
shows in 2021 a revenue of 2.3 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE CENTRALE VEYNES (SIREN 523653889)
Indicator
2025
2024
2022
2021
2020
2019
2018
2017
Revenue
N/C
N/C
N/C
2 289 827 €
N/C
N/C
N/C
N/C
Net income
-7 571 €
29 442 €
82 106 €
88 875 €
115 683 €
72 874 €
61 169 €
70 012 €
EBITDA
N/C
N/C
N/C
126 660 €
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
3.9%
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, PHARMACIE CENTRALE VEYNES records a net loss of 8 k€. This deficit will reduce equity on the balance sheet.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
-7 571 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 54%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 55%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
54.036%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
55.052%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE CENTRALE VEYNES
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2024
2025
Debt ratio
255.341
209.098
167.172
125.761
96.065
77.951
53.637
54.036
Financial autonomy
25.962
29.307
33.139
38.951
44.13
49.583
55.393
55.052
Repayment capacity
None
None
None
None
8.214
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
4.187%
None%
None%
None%
Sector positioning
Debt ratio
54.042025
2022
2024
2025
Q1: 13.57
Med: 49.47
Q3: 128.28
Average
In 2025, the debt ratio of PHARMACIE CENTRALE VEYNES (54.04) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
55.05%2025
2022
2024
2025
Q1: 33.69%
Med: 53.88%
Q3: 72.26%
Good
In 2025, the financial autonomy of PHARMACIE CENTRALE VEYNES (55.0%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 108.21. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
108.208
Liquidity indicators evolution PHARMACIE CENTRALE VEYNES
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
2022
2024
2025
Liquidity ratio
187.55
163.118
138.102
141.115
124.068
127.514
113.313
108.208
Interest coverage
None
None
None
None
5.601
None
None
None
Sector positioning
Liquidity ratio
108.212025
2022
2024
2025
Q1: 131.48
Med: 182.6
Q3: 258.72
Watch
In 2025, the liquidity ratio of PHARMACIE CENTRALE VEYNES (108.21) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE CENTRALE VEYNES
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2024
2025
Operating WCR
0 €
0 €
0 €
0 €
217 602 €
0 €
0 €
0 €
Inventory turnover (days)
0
0
0
0
36
0
0
0
Customer payment term (days)
0
0
0
0
3
0
0
0
Supplier payment term (days)
0
0
0
0
35
0
0
0
Positioning of PHARMACIE CENTRALE VEYNES in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE CENTRALE VEYNES with other companies in the same sector:
Frequently asked questions about PHARMACIE CENTRALE VEYNES
What is the revenue of PHARMACIE CENTRALE VEYNES ?
The revenue of PHARMACIE CENTRALE VEYNES in 2021 is 2.3 M€.
Is PHARMACIE CENTRALE VEYNES profitable?
PHARMACIE CENTRALE VEYNES recorded a net loss in 2025.
Where is the headquarters of PHARMACIE CENTRALE VEYNES ?
The headquarters of PHARMACIE CENTRALE VEYNES is located in VEYNES (05400), in the department Hautes-Alpes.
Where to find the tax return of PHARMACIE CENTRALE VEYNES ?
The tax return of PHARMACIE CENTRALE VEYNES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE CENTRALE VEYNES operate?
PHARMACIE CENTRALE VEYNES operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart